Bonomo, S.; Giovannoni, R.; Lavitrano, M.; Cadamuro, M.; Conconi, D.
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy. Int. J. Mol. Sci. 2025, 26, 11250.
https://doi.org/10.3390/ijms262311250
AMA Style
Bonomo S, Giovannoni R, Lavitrano M, Cadamuro M, Conconi D.
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy. International Journal of Molecular Sciences. 2025; 26(23):11250.
https://doi.org/10.3390/ijms262311250
Chicago/Turabian Style
Bonomo, Sara, Roberto Giovannoni, Marialuisa Lavitrano, Massimiliano Cadamuro, and Donatella Conconi.
2025. "TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy" International Journal of Molecular Sciences 26, no. 23: 11250.
https://doi.org/10.3390/ijms262311250
APA Style
Bonomo, S., Giovannoni, R., Lavitrano, M., Cadamuro, M., & Conconi, D.
(2025). TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy. International Journal of Molecular Sciences, 26(23), 11250.
https://doi.org/10.3390/ijms262311250